Logo image of TUB.BR

FINANCIERE DE TUBIZE (TUB.BR) Stock Fundamental Analysis

EBR:TUB - BE0003823409 - Common Stock

163.6 EUR
+1.2 (+0.74%)
Last: 9/4/2025, 5:29:53 PM
Fundamental Rating

3

Taking everything into account, TUB scores 3 out of 10 in our fundamental rating. TUB was compared to 50 industry peers in the Pharmaceuticals industry. While TUB has a great health rating, there are worries on its profitability. TUB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TUB had positive earnings in the past year.
TUB had a negative operating cash flow in the past year.
TUB had positive earnings in each of the past 5 years.
TUB had a negative operating cash flow in each of the past 5 years.
TUB.BR Yearly Net Income VS EBIT VS OCF VS FCFTUB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

TUB has a Return On Assets (4.79%) which is in line with its industry peers.
TUB's Return On Equity of 4.79% is in line compared to the rest of the industry. TUB outperforms 42.00% of its industry peers.
Industry RankSector Rank
ROA 4.79%
ROE 4.79%
ROIC N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
TUB.BR Yearly ROA, ROE, ROICTUB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TUB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TUB.BR Yearly Profit, Operating, Gross MarginsTUB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

More info and screens

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, TUB has about the same amount of shares outstanding.
Compared to 5 years ago, TUB has more shares outstanding
The debt/assets ratio for TUB has been reduced compared to a year ago.
TUB.BR Yearly Shares OutstandingTUB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TUB.BR Yearly Total Debt VS Total AssetsTUB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TUB has an Altman-Z score of 11818.81. This indicates that TUB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of TUB (11818.81) is better than 100.00% of its industry peers.
There is no outstanding debt for TUB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11818.81
ROIC/WACCN/A
WACCN/A
TUB.BR Yearly LT Debt VS Equity VS FCFTUB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 10.33 indicates that TUB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 10.33, TUB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
TUB has a Quick Ratio of 10.33. This indicates that TUB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 10.33, TUB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.33
Quick Ratio 10.33
TUB.BR Yearly Current Assets VS Current LiabilitesTUB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.02% over the past year.
The earnings per share for TUB have been decreasing by -20.68% on average. This is quite bad
EPS 1Y (TTM)3.02%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TUB.BR Yearly Revenue VS EstimatesTUB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M 250M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TUB is valuated quite expensively with a Price/Earnings ratio of 78.65.
68.00% of the companies in the same industry are cheaper than TUB, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.84. TUB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 78.65
Fwd PE N/A
TUB.BR Price Earnings VS Forward Price EarningsTUB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TUB.BR Per share dataTUB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.45%, TUB is not a good candidate for dividend investing.
TUB's Dividend Yield is comparable with the industry average which is at 3.04.
Compared to an average S&P500 Dividend Yield of 2.32, TUB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.45%

5.2 History

On average, the dividend of TUB grows each year by 7.33%, which is quite nice.
Dividend Growth(5Y)7.33%
Div Incr Years0
Div Non Decr Years0
TUB.BR Yearly Dividends per shareTUB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

0.05% of the earnings are spent on dividend by TUB. This is a low number and sustainable payout ratio.
DP0.05%
EPS Next 2YN/A
EPS Next 3YN/A
TUB.BR Yearly Income VS Free CF VS DividendTUB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M
TUB.BR Dividend Payout.TUB.BR Dividend Payout, showing the Payout Ratio.TUB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

FINANCIERE DE TUBIZE

EBR:TUB (9/4/2025, 5:29:53 PM)

163.6

+1.2 (+0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-02 2025-08-02
Earnings (Next)N/A N/A
Inst Owners2.69%
Inst Owner ChangeN/A
Ins Owners33.27%
Ins Owner ChangeN/A
Market Cap7.28B
Analysts83.33
Price Target189.98 (16.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.45%
Yearly Dividend0.97
Dividend Growth(5Y)7.33%
DP0.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.92%
PT rev (3m)1.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 78.65
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.76
P/tB 3.76
EV/EBITDA N/A
EPS(TTM)2.08
EY1.27%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS43.5
TBVpS43.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 4.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.33
Quick Ratio 10.33
Altman-Z 11818.81
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.02%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.98%
OCF growth 3YN/A
OCF growth 5YN/A